XBiotech (XBIT) Accumulated Expenses (2014 - 2026)
XBiotech (XBIT) posted quarterly Accumulated Expenses of $6.3 million for Q4 2025, up 140.05% year-over-year from $2.6 million in Q4 2024, and up 160.86% quarter-over-quarter from $2.4 million in Q3 2025.
XBiotech (XBIT) Accumulated Expenses (2014 - 2026) Analysis & Trends
XBiotech's Accumulated Expenses history runs 12 years deep, the most recent figure standing at $6.3 million for Q4 2025.
- In Q4 2025, Accumulated Expenses rose 140.05% year-over-year to $6.3 million; the TTM figure through Dec 2025 stood at $6.3 million (up 140.05% YoY), while the FY2025 annual figure was $6.3 million, up 140.05% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $6.3 million, up from $2.4 million in the prior quarter.
- The five-year high for Accumulated Expenses was $6.3 million in Q4 2025, with the low at $562000.0 in Q4 2023.
- The 5-year median for Accumulated Expenses is $2.4 million (2025), against an average of $2.9 million.
- The sharpest annual moves came in 2021 and 2024: Accumulated Expenses tumbled 65.2% in 2021, then soared 368.33% in 2024.
- XBiotech's Accumulated Expenses stood at $1.4 million in 2021, then rose by 16.67% to $1.6 million in 2022, then plunged by 64.94% to $562000.0 in 2023, then jumped by 368.33% to $2.6 million in 2024, then soared by 140.05% to $6.3 million in 2025.
- Business Quant data shows XBIT's Accumulated Expenses at $6.3 million in Q4 2025, $2.4 million in Q3 2025, and $2.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.25 Mn |
| Dec 31, 2025 | 6.32 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 562,000.00 |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 2.21 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 5.59 Mn |
| Mar 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.64 Mn |
| Jun 30, 2021 | 1.68 Mn |